Firefly Neuroscience, Inc. (AIFF)

CA — Technology Sector

Peers:

Automate Your Wheel Strategy on AIFF

With Tiblio's Option Bot, you can configure your own wheel strategy including AIFF - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol AIFF
Rev/Share 0.2041
Book/Share 0.5207
PB 5.8378
Debt/Equity 0.0
CurrentRatio 1.4457
ROIC -1.958

MktCap 39097744.0
FreeCF/Share -0.7671
PFCF -5.1188
PE -1.4149
Debt/Assets 0.0
DivYield 0
ROE -9.5454

Rating C-
Score 1
Recommendation Strong Sell
P/E Score 1
DCF Score 3
P/B Score 1
D/E Score 1

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
No ratings available.

News

Firefly Neuroscience to be Added to the Russell Microcap® Index

AIFF
Published: June 23, 2025 by: GlobeNewsWire
Sentiment: Neutral

– Comes less than a year after listing on Nasdaq – KENMORE, N.Y., June 23, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that it will be added to the Russell Microcap® Index as part of this year's reconstitution.

image for news Firefly Neuroscience to be Added to the Russell Microcap® Index

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

AIFF
Published: May 05, 2025 by: GlobeNewsWire
Sentiment: Neutral

A correction from source is being issued with respect to the press release titled, Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc., released on May 5, 2025 at 8:00 am ET. Please note, the correct form of payment of the potential Evoke investors' earn-out is in Firefly's common stock. The complete corrected press release follows:

image for news Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

AIFF
Published: February 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

Extends cash runway well into mid-2026; no new/replacement warrants issued Extends cash runway well into mid-2026; no new/replacement warrants issued

image for news Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Firefly Neuroscience Accepted into NVIDIA Connect Program

AIFF
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral

Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform

image for news Firefly Neuroscience Accepted into NVIDIA Connect Program

About Firefly Neuroscience, Inc. (AIFF)

IPO Date 2002-11-28
Website https://fireflyneuro.com
Industry Software - Application
CEO Greg Lipschitz
Employees 13

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.